(Q51686636)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

title

Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

0 references

1 reference

Dermatophagoides pteronyssinus

1 reference

based on heuristic

inferred from title

author

Giorgio Walter Canonica

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

author name string

V Di Rienzo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

F Marcucci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

P Puccinelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

S Parmiani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

F Frati

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

L Sensi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

G Passalacqua

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

Clinical & Experimental Allergy

18 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

page(s)

206-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

18 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Safety of sublingual-swallow immunotherapy in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Sublingual immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2222.2003.01587.X

10.1046/J.1365-2222.2003.01587.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12580913 AND SRC:MED&resulttype=core&format=json

18 December 2019

1 reference